Search results
Results from the WOW.Com Content Network
EE/CPA is used as a combined birth control pill to prevent ovulation and pregnancy in women. [2] It is also approved and used to treat androgen-dependent conditions in women such as acne , seborrhea , hirsutism , female pattern hair loss , and hyperandrogenism due to polycystic ovary syndrome .
Hyperandrogenism is a medical condition characterized by high levels of androgens.It is more common in women than men. [4] Symptoms of hyperandrogenism may include acne, seborrhea, hair loss on the scalp, increased body or facial hair, and infrequent or absent menstruation.
Treatments may include certain birth control pills, antiandrogens, or insulin sensitizers. [1] Hirsutism affects between 5 and 15% of women across all ethnic backgrounds. [8] Depending on the definition and the underlying data, approximately 40% of women have some degree of facial hair. [9]
For generations, women have mostly shouldered the birth control burden. The pill was introduced in the 1960s, and new options, like patches and IUDs, have become available over the years.
The phase 2 trial included 222 men aged 18 to 50, all of whom used around a teaspoon of the hormone gel, made up of the hormones testosterone and segesterone acetate, on each shoulder blade daily.
Ongoing research presented at the Endocrine Society’s annual meeting shows promise for a new male contraceptive option. The product, a gel, has shown effectiveness beyond what researchers ...
Cyproterone acetate (CPA), sold alone under the brand name Androcur or with ethinylestradiol under the brand names Diane or Diane-35 among others, is an antiandrogen and progestin medication used in the treatment of androgen-dependent conditions such as acne, excessive body hair growth, early puberty, and prostate cancer, as a component of feminizing hormone therapy for transgender individuals ...
What you need to know about over-the-counter birth control. OTC birth control pills are a newer option for people in the U.S. In July 2023, the Food and Drug Administration (FDA) approved Opill as ...